Scarica l'app Stockscreener
32.53
1.32%
0.425
Dopo l'orario di chiusura:
32.35
-0.185
-0.57%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$32.11
Aprire:
$32.5
Volume 24 ore:
604.21K
Relative Volume:
1.15
Capitalizzazione di mercato:
$1.65B
Reddito:
$276.26M
Utile/perdita netta:
$16.52M
Rapporto P/E:
105.70
EPS:
0.3078
Flusso di cassa netto:
$24.75M
1 W Prestazione:
-3.49%
1M Prestazione:
-9.52%
6M Prestazione:
+1.10%
1 anno Prestazione:
-28.32%
Intervallo 1D:
$31.16
$32.65
Intervallo di 1 settimana:
$31.16
$34.79
Portata 52W:
$29.24
$48.74
Vericel Corp Stock (VCEL) Company Profile
Nome
Vericel Corp
Settore
Industria
Telefono
(734) 930-5555
Indirizzo
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
32.53 | 1.65B | 276.26M | 16.52M | 24.75M | 0.3078 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-08-09 | Iniziato | Canaccord Genuity | Buy |
| 2024-06-20 | Iniziato | TD Cowen | Buy |
| 2024-01-25 | Aggiornamento | Truist | Hold → Buy |
| 2023-08-08 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-11-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-11-09 | Downgrade | Truist | Buy → Hold |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2021-01-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Iniziato | Stephens | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2019-10-09 | Iniziato | H.C. Wainwright | Buy |
| 2019-02-28 | Downgrade | Needham | Buy → Hold |
| 2018-08-08 | Reiterato | Needham | Buy |
| 2018-07-16 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | Iniziato | Leerink Partners | Outperform |
| 2018-03-06 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | Reiterato | Needham | Buy |
| 2018-03-05 | Reiterato | BTIG Research | Buy |
| 2017-06-21 | Iniziato | BTIG Research | Buy |
| 2017-03-13 | Reiterato | Needham | Buy |
| 2016-12-22 | Iniziato | Piper Jaffray | Overweight |
| 2016-11-09 | Reiterato | Needham | Buy |
| 2016-04-05 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | Aggiornamento | Needham | Hold → Buy |
Mostra tutto
Vericel Corp Borsa (VCEL) Ultime notizie
What Makes Vericel Corporation (VCEL) an Investment Bet? - Yahoo Finance
Dilated Cardiomyopathy Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Bristol Myers Squibb, Berlin Cures, Cumberland Pharma, Vericel Corp, Corimmun GmbH, Pfizer, Constant Therapeut - Barchart.com
Dilated Cardiomyopathy Market: Rapid Growth & Investment - openPR.com
Bank Watch: Can Vericel Corporation sustain earnings growth2026 Recap & Safe Entry Point Alerts - baoquankhu1.vn
Leerink reiterates Outperform on Vericel stock, $46 target - Investing.com
Vericel at Leerink Global Healthcare: Strategic Growth and Expansion - Investing.com
FDA MACI Approval Tests Vericel’s Capacity Plans And Growth Story - finance.yahoo.com
Vericel Corporation (VCEL) Secures FDA Approval for Commercial Manufacturing of MACI - Finviz
Vericel (VCEL) Valuation In Focus After FDA Clears MACI Commercial Manufacturing Capacity - simplywall.st
Vericel (NASDAQ:VCEL) Downgraded by Wall Street Zen to Hold - MarketBeat
Vericel (VCEL) Is Down 9.8% After FDA Clears New MACI Plant – Has The Bull Case Changed? - simplywall.st
Vericel wins FDA approval for MACI production at new facility - Investing.com
Insider Sell: Michael Halpin Sells 10,305 Shares of Vericel Corp (VCEL) - GuruFocus
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion By Investing.com - Investing.com Australia
FDA Greenlights Vericel (VCEL) Facility for MACI Production - GuruFocus
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility - The Manila Times
FDA approves new Vericel cell therapy plant to expand cartilage repair - Stock Titan
Sports injury and burn care firm Vericel heads to investor conferences - Stock Titan
Affiliate sale notice for Vericel (NASDAQ: VCEL) — 15,000 shares listed - Stock Titan
VCEL (NASDAQ: VCEL) Form 144 lists vested share sale entries - Stock Titan
H.C. Wainwright raises Vericel stock price target on revenue growth By Investing.com - Investing.com Canada
William Blair Investment Management LLC Buys 1,048,864 Shares of Vericel Corporation $VCEL - MarketBeat
H.C. Wainwright raises Vericel stock price target on revenue growth - Investing.com
Equities Analysts Offer Predictions for Vericel Q4 Earnings - Defense World
HC Wainwright Boosts Vericel (NASDAQ:VCEL) Price Target to $64.00 - Defense World
A Look At Vericel (VCEL) Valuation After Record 2025 Results And Upbeat 2026 Growth Guidance - Yahoo Finance
Should You Buy Vericel Corp (VCEL) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
VCEL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Vericel (NASDAQ:VCEL) Given New $64.00 Price Target at HC Wainwright - MarketBeat
VCEL Analyst Rating: HC Wainwright & Co. Raises Price Target | V - GuruFocus
Vericel Corporation (NASDAQ:VCEL) Q4 2025 Earnings Call Transcript - Insider Monkey
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Breakout Case - ChartMill
Vericel (VCEL) EPS Jump In Q4 2025 Tests Premium 115x P/E Narrative - simplywall.st
Decoding Vericel Corp (VCEL): A Strategic SWOT Insight - GuruFocus
Vericel Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Vericel (NASDAQ:VCEL) Issues Quarterly Earnings Results - MarketBeat
Vericel (VCEL) CEO logs RSU vesting, phantom stock deferral and tax shares - Stock Titan
Vericel (VCEL) CMO logs RSU vesting, phantom stock and tax share withholdings - Stock Titan
RSU vesting boosts Vericel (VCEL) officer Siegal’s shareholding - Stock Titan
Vericel (VCEL) CFO logs RSU vesting and tax withholding share dispositions - Stock Titan
COO at Vericel (VCEL) gains stock through RSU vesting and tax withholding - Stock Titan
Vericel (VCEL) CLO reports RSU vesting, share withholding for taxes - Stock Titan
Vericel Corporation (VCEL) Matches Q4 Earnings Estimates - Yahoo Finance
Vericel Q4 2025 slides: record margins offset by 2026 guidance - Investing.com
Earnings call transcript: Vericel beats Q4 2025 forecasts, stock dips By Investing.com - Investing.com Australia
Earnings call transcript: Vericel beats Q4 2025 forecasts, stock dips - Investing.com India
Vericel Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Vericel Corp (NASDAQ:VCEL) Reports Q4 2025 Earnings In Line, Beats on Profitability - ChartMill
Vericel Corp Ord earnings beat by $0.06, revenue topped estimates - Investing.com Canada
Vericel Corp SEC 10-K Report - TradingView
VERICEL ($VCEL) Releases Q4 2025 Earnings - Quiver Quantitative
Vericel Corp Azioni (VCEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):